Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Arch Neurol

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    December 2012
  1. JAGUST W
    Apolipoprotein E, Neurodegeneration, and Alzheimer Disease.
    Arch Neurol. 2012 Dec 3:1-2. doi: 10.1001/jamaneurol.2013.
    PubMed     Text format     Related articles   


    November 2012
  2. DOROTHEE G , de Souza LC, Sarazin M, Aucouturier P, et al
    Plasma Anti-Amyloid-beta Autoantibodies in All Alzheimer Disease Types-Reply.
    Arch Neurol. 2012;69:1525-7.
    PubMed     Text format     Related articles   


  3. TREMOLIZZO L , Conti E, Appollonio I, Ferrarese C, et al
    Plasma Anti-Amyloid-beta Autoantibodies in All Alzheimer Disease Types.
    Arch Neurol. 2012;69:1525-7.
    PubMed     Text format     Related articles   


    September 2012
  4. WEINER MF
    Impact of Delirium on the Course of Alzheimer Disease.
    Arch Neurol. 2012 Sep 17:1-2. doi: 10.1001/archneurol.2012.2703.
    PubMed     Text format     Related articles    Abstract available


  5. HAJJAR I , Brown L, Mack WJ, Chui H, et al
    Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series.
    Arch Neurol. 2012 Sep 10:1-7. doi: 10.1001/archneurol.2012.1010.
    PubMed     Text format     Related articles    Abstract available


  6. BRICKMAN AM , Provenzano FA, Muraskin J, Manly JJ, et al
    Regional White Matter Hyperintensity Volume, Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the Community.
    Arch Neurol. 2012 Sep 3:1-7. doi: 10.1001/archneurol.2012.1527.
    PubMed     Text format     Related articles    Abstract available


    August 2012
  7. CORIC V , van Dyck CH, Salloway S, Andreasen N, et al
    Safety and Tolerability of the gamma-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease.
    Arch Neurol. 2012 Aug 13:1-12. doi: 10.1001/archneurol.2012.2194.
    PubMed     Text format     Related articles    Abstract available


  8. JUN G , Vardarajan BN, Buros J, Yu CE, et al
    Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region.
    Arch Neurol. 2012 Aug 6:1-10. doi: 10.1001/archneurol.2012.2052.
    PubMed     Text format     Related articles    Abstract available


  9. GUERREIRO RJ , Hardy J
    TOMM40 Association With Alzheimer Disease: Tales of APOE and Linkage Disequilibrium.
    Arch Neurol. 2012 Aug 6:1-2. doi: 10.1001/archneurol.2012.1935.
    PubMed     Text format     Related articles   


  10. HONIG LS
    Translational research in neurology: dementia.
    Arch Neurol. 2012;69:969-77.
    PubMed     Text format     Related articles    Abstract available


    July 2012
  11. WAGNER SL , Tanzi RE, Mobley WC, Galasko D, et al
    Potential Use of gamma-Secretase Modulators in the Treatment of Alzheimer Disease.
    Arch Neurol. 2012 Jul 16:1-4. doi: 10.1001/archneurol.2012.
    PubMed     Text format     Related articles    Abstract available


  12. DOECKE JD , Laws SM, Faux NG, Wilson W, et al
    Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease.
    Arch Neurol. 2012 Jul 16:1-8. doi: 10.1001/archneurol.2012.1282.
    PubMed     Text format     Related articles    Abstract available


  13. SOARES HD , Potter WZ, Pickering E, Kuhn M, et al
    Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease.
    Arch Neurol. 2012 Jul 16:1-8. doi: 10.1001/archneurol.2012.1070.
    PubMed     Text format     Related articles    Abstract available


  14. WANG HX
    Physical activity and AD-related pathology.
    Arch Neurol. 2012;69:940-1.
    PubMed     Text format     Related articles   


  15. KOYAMA A , Okereke OI, Yang T, Blacker D, et al
    Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis.
    Arch Neurol. 2012;69:824-31.
    PubMed     Text format     Related articles    Abstract available


  16. LE PERA M , Urso E, Sprovieri T, Bossio S, et al
    Contribution of cerebrospinal fluid thymosin beta4 levels to the clinical differentiation of Creutzfeldt-Jakob disease.
    Arch Neurol. 2012;69:868-72.
    PubMed     Text format     Related articles    Abstract available


  17. JUNG S , Zarow C, Mack WJ, Zheng L, et al
    Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease.
    Arch Neurol. 2012;69:879-86.
    PubMed     Text format     Related articles    Abstract available


    June 2012
  18. DOROTHEE G , Bottlaender M, Moukari E, de Souza LC, et al
    Distinct Patterns of Antiamyloid-beta Antibodies in Typical and Atypical Alzheimer DiseaseDistinct Patterns of Anti-Abeta Antibodies and AD.
    Arch Neurol. 2012 Jun 18:1-5. doi: 10.1001/archneurol.2012.
    PubMed     Text format     Related articles    Abstract available


  19. RINGMAN JM , Elashoff D, Geschwind DH, Welsh BT, et al
    Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer Disease: Influence of APOE GenotypePlasma Biomarkers and AD Genetic Risk.
    Arch Neurol. 2012;69:757-64.
    PubMed     Text format     Related articles    Abstract available


  20. DESIKAN RS , McEvoy LK, Thompson WK, Holland D, et al
    Amyloid-beta--associated clinical decline occurs only in the presence of elevated P-tau.
    Arch Neurol. 2012;69:709-13.
    PubMed     Text format     Related articles    Abstract available


  21. HOLTZMAN DM
    CSF biomarkers for secondary prevention trials: why markers of amyloid deposition and neurodegeneration are both important.
    Arch Neurol. 2012;69:691-2.
    PubMed     Text format     Related articles   


    May 2012
  22. SMITH GS , Laxton AW, Tang-Wai DF, McAndrews MP, et al
    Increased Cerebral Metabolism After 1 Year of Deep Brain Stimulation in Alzheimer Disease.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available



  23. Insulin and Alzheimer disease-reply.
    Arch Neurol. 2012;69:670-1.
    PubMed     Text format     Related articles   



  24. Insulin and Alzheimer disease.
    Arch Neurol. 2012;69:670-1.
    PubMed     Text format     Related articles   


  25. WHITWELL JL , Wiste HJ, Weigand SD, Rocca WA, et al
    Comparison of imaging biomarkers in the Alzheimer disease neuroimaging initiative and the mayo clinic study of aging.
    Arch Neurol. 2012;69:614-22.
    PubMed     Text format     Related articles    Abstract available


  26. LANDAU SM , Marks SM, Mormino EC, Rabinovici GD, et al
    Association of lifetime cognitive engagement and low beta-amyloid deposition.
    Arch Neurol. 2012;69:623-29.
    PubMed     Text format     Related articles    Abstract available


    April 2012
  27. IRWIN DJ , McMillan CT, Toledo JB, Arnold SE, et al
    Comparison of Cerebrospinal Fluid Levels of Tau and Abeta 1-42 in Alzheimer Disease and Frontotemporal Degeneration Using 2 Analytical Platforms.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  28. BLENNOW K , Zetterberg H, Rinne JO, Salloway S, et al
    Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  29. BOXER AL , Garbutt S, Seeley WW, Jafari A, et al
    Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.
    Arch Neurol. 2012;69:509-17.
    PubMed     Text format     Related articles    Abstract available


    March 2012
  30. GALASKO DR , Peskind E, Clark CM, Quinn JF, et al
    Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  31. BERNICK C , Cummings J, Raman R, Sun X, et al
    Age and Rate of Cognitive Decline in Alzheimer Disease: Implications for Clinical Trials.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  32. JACK CR JR , Vemuri P, Wiste HJ, Weigand SD, et al
    Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  33. REITZ C , Conrad C, Roszkowski K, Rogers RS, et al
    Effect of Genetic Variation in LRRTM3 on Risk of Alzheimer Disease.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  34. GLODZIK L , Galvin J, Pirraglia E, de Leon M, et al
    Ordering of Alzheimer disease biomarkers.
    Arch Neurol. 2012;69:414.
    PubMed     Text format     Related articles   


  35. CAGLAYAN S , Bauerfeind A, Schmidt V, Carlo AS, et al
    Identification of Alzheimer Disease Risk Genotype That Predicts Efficiency of SORL1 Expression in the Brain.
    Arch Neurol. 2012;69:373-9.
    PubMed     Text format     Related articles    Abstract available


  36. IRIZARRY MC , Jin S, He F, Emond JA, et al
    Incidence of new-onset seizures in mild to moderate Alzheimer disease.
    Arch Neurol. 2012;69:368-72.
    PubMed     Text format     Related articles    Abstract available


    February 2012
  37. MORRIS JC
    Revised Criteria for Mild Cognitive Impairment May Compromise the Diagnosis of Alzheimer Disease Dementia.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  38. MOGHEKAR A , Goh J, Li M, Albert M, et al
    Cerebrospinal fluid Abeta and tau level fluctuation in an older clinical cohort.
    Arch Neurol. 2012;69:246-50.
    PubMed     Text format     Related articles    Abstract available


    January 2012
  39. VAN HIMBERGEN TM , Beiser AS, Ai M, Seshadri S, et al
    Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study.
    Arch Neurol. 2012.
    PubMed     Text format     Related articles    Abstract available


  40. RINGMAN JM , Schulman H, Becker C, Jones T, et al
    Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.
    Arch Neurol. 2012;69:96-104.
    PubMed     Text format     Related articles    Abstract available


  41. ANCES BM , Benzinger TL, Christensen JJ, Thomas J, et al
    11C-PiB Imaging of Human Immunodeficiency Virus-Associated Neurocognitive Disorder.
    Arch Neurol. 2012;69:72-7.
    PubMed     Text format     Related articles    Abstract available


    December 2011
  42. LOGUE MW , Schu M, Vardarajan BN, Buros J, et al
    A Comprehensive Genetic Association Study of Alzheimer Disease in African Americans.
    Arch Neurol. 2011;68:1569-1579.
    PubMed     Text format     Related articles    Abstract available


    November 2011
  43. SABBAGH MN , Fleisher A, Chen K, Rogers J, et al
    Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-beta in a Patient With Down Syndrome and Alzheimer Disease.
    Arch Neurol. 2011;68:1461-6.
    PubMed     Text format     Related articles    Abstract available


  44. HARDY J , Guerreiro R, Lovestone S
    Clusterin as an Alzheimer biomarker.
    Arch Neurol. 2011;68:1459-60.
    PubMed     Text format     Related articles   


  45. SHEPARDSON NE , Shankar GM, Selkoe DJ
    Cholesterol Level and Statin Use in Alzheimer Disease: II. Review of Human Trials and Recommendations.
    Arch Neurol. 2011;68:1385-92.
    PubMed     Text format     Related articles    Abstract available


  46. JAGUST WJ
    Amyloid imaging: liberal or conservative? Let the data decide.
    Arch Neurol. 2011;68:1377-8.
    PubMed     Text format     Related articles   


    October 2011
  47. OSTROWITZKI S , Deptula D, Thurfjell L, Barkhof F, et al
    Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  48. XIONG C , Roe CM, Buckles V, Fagan A, et al
    Role of family history for Alzheimer biomarker abnormalities in the adult children study.
    Arch Neurol. 2011;68:1313-9.
    PubMed     Text format     Related articles    Abstract available


  49. SHEPARDSON NE , Shankar GM, Selkoe DJ
    Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.
    Arch Neurol. 2011;68:1239-44.
    PubMed     Text format     Related articles    Abstract available


  50. LO RY , Hubbard AE, Shaw LM, Trojanowski JQ, et al
    Longitudinal change of biomarkers in cognitive decline.
    Arch Neurol. 2011;68:1257-66.
    PubMed     Text format     Related articles    Abstract available


    September 2011
  51. WINGO TS , Lah JJ, Levey AI, Cutler DJ, et al
    Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  52. CRAFT S , Baker LD, Montine TJ, Minoshima S, et al
    Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  53. MULLER U , Winter P, Graeber MB
    Alois Alzheimer's Case, Auguste D., Did Not Carry the N141I Mutation in PSEN2 Characteristic of Alzheimer Disease in Volga Germans.
    Arch Neurol. 2011;68:1210-1.
    PubMed     Text format     Related articles   


  54. SCHMIDT C , Wolff M, Weitz M, Bartlau T, et al
    Rapidly progressive Alzheimer disease.
    Arch Neurol. 2011;68:1124-30.
    PubMed     Text format     Related articles    Abstract available


  55. ROE CM , Fagan AM, Grant EA, Marcus DS, et al
    Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.
    Arch Neurol. 2011;68:1145-51.
    PubMed     Text format     Related articles    Abstract available


    August 2011
  56. JACK CR JR , Vemuri P, Wiste HJ, Weigand SD, et al
    Evidence for Ordering of Alzheimer Disease Biomarkers.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  57. SABUNCU MR , Desikan RS, Sepulcre J, Yeo BT, et al
    The Dynamics of Cortical and Hippocampal Atrophy in Alzheimer Disease.
    Arch Neurol. 2011;68:1040-1048.
    PubMed     Text format     Related articles    Abstract available


  58. CRUCHAGA C , Nowotny P, Kauwe JS, Ridge PG, et al
    Association and Expression Analyses With Single-Nucleotide Polymorphisms in TOMM40 in Alzheimer Disease.
    Arch Neurol. 2011;68:1013-1019.
    PubMed     Text format     Related articles    Abstract available


  59. SONNEN JA , Santa Cruz K, Hemmy LS, Woltjer R, et al
    Ecology of the aging human brain.
    Arch Neurol. 2011;68:1049-56.
    PubMed     Text format     Related articles    Abstract available


    July 2011
  60. FLEISHER AS , Chen K, Liu X, Roontiva A, et al
    Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  61. VILLEMAGNE VL , Okamura N, Pejoska S, Drago J, et al
    In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
    Arch Neurol. 2011;68:905-12.
    PubMed     Text format     Related articles    Abstract available


  62. LANDT J , D'Abrera JC, Holland AJ, Aigbirhio FI, et al
    Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar beta-amyloid in adults with down syndrome: safety, acceptability, and feasibility.
    Arch Neurol. 2011;68:890-6.
    PubMed     Text format     Related articles    Abstract available


    June 2011
  63. ROSENBERG RN
    Treat Alzheimer Disease Before It Is Symptomatic.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles   


  64. HACHINSKI V
    Stroke and Alzheimer disease: fellow travelers or partners in crime?
    Arch Neurol. 2011;68:797-8.
    PubMed     Text format     Related articles   


  65. NELSON LD , Siddarth P, Kepe V, Scheibel KE, et al
    Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome.
    Arch Neurol. 2011;68:768-74.
    PubMed     Text format     Related articles    Abstract available


  66. BAYER-CARTER JL , Green PS, Montine TJ, VanFossen B, et al
    Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.
    Arch Neurol. 2011;68:743-52.
    PubMed     Text format     Related articles    Abstract available


    May 2011
  67. FAGAN AM , Shaw LM, Xiong C, Vanderstichele H, et al
    Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of {beta}-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  68. DAVIGLUS ML , Plassman BL, Pirzada A, Bell CC, et al
    Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  69. LASKE C
    Blood-based biomarkers in Alzheimer disease.
    Arch Neurol. 2011;68:685-6.
    PubMed     Text format     Related articles   


  70. ATRI A , O'Brien JL, Sreenivasan A, Rastegar S, et al
    Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.
    Arch Neurol. 2011;68:599-606.
    PubMed     Text format     Related articles    Abstract available


  71. YAFFE K , Middleton LE, Lui LY, Spira AP, et al
    Mild cognitive impairment, dementia, and their subtypes in oldest old women.
    Arch Neurol. 2011;68:631-6.
    PubMed     Text format     Related articles    Abstract available


  72. CRUCHAGA C , Graff C, Chiang HH, Wang J, et al
    Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.
    Arch Neurol. 2011;68:581-6.
    PubMed     Text format     Related articles    Abstract available


    April 2011
  73. HYMAN BT
    Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles   


  74. SCHNEIDER LS , Dagerman KS, Higgins JP, McShane R, et al
    Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available


  75. SAKURAI T
    Targets of the Peroxisome Proliferator-Activated Receptor {gamma} Agonist Trials for the Prevention of Alzheimer Disease.
    Arch Neurol. 2011;68:542.
    PubMed     Text format     Related articles   


    March 2011
  76. KUHLMANN D
    Primum non nocere.
    Arch Neurol. 2011;68:397-8.
    PubMed     Text format     Related articles   


  77. SETO-SALVIA N , Clarimon J, Pagonabarraga J, Pascual-Sedano B, et al
    Dementia Risk in Parkinson Disease: Disentangling the Role of MAPT Haplotypes.
    Arch Neurol. 2011;68:359-64.
    PubMed     Text format     Related articles    Abstract available


  78. WOMACK KB , Diaz-Arrastia R, Aizenstein HJ, Arnold SE, et al
    Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
    Arch Neurol. 2011;68:329-37.
    PubMed     Text format     Related articles    Abstract available


    February 2011
  79. REIJMER Y , Biessels GJ
    Vascular risk scores for dementia: age matters.
    Arch Neurol. 2011;68:267.
    PubMed     Text format     Related articles   


  80. GEERLINGS MI , Vergouwe Y
    Improving risk scores for dementia.
    Arch Neurol. 2011;68:267-8.
    PubMed     Text format     Related articles   


  81. SOJKOVA J , Driscoll I, Iacono D, Zhou Y, et al
    In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.
    Arch Neurol. 2011;68:232-40.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: